Equities

IMD International Medical Devices SpA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

IMD International Medical Devices SpA

Actions
  • Price (EUR)1.08
  • Today's Change-0.21 / -16.28%
  • Shares traded12.00k
  • 1 Year change-23.40%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 07:20 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

IMD International Medical Devices SpA, also known as IMD Group, is an Italy-based holding company engaged in the design, development, manufacturing, and distribution of diagnostic systems. The Company operates through its subsidiaries and the activities of the IMD Group are divided into two business areas: X-Ray Generators (through the subsidiary IMD Generators) that develops, manufactures and distributes components for medical equipment such as monoblocs, generators and control systems; X-Ray Imaging Devices (through the subsidiaries Technix and Intermedical) that develops, manufactures and distributes the complete medical equipment based on X-ray technology for different health departments. IMD Group serves customers globally.

  • Revenue in EUR (TTM)36.29m
  • Net income in EUR1.34m
  • Incorporated1981
  • Employees121.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.